I think it is fair to say that R&D is the lifeblood of the pharma industry, and no drug discovery program can be completed without its clinical trials.
What is disease progression (HPD)? Hyperprogression of disease (HPD) is a model of NSCLC progression, a concept relative to "progression", defined as the rate of tumor growth after treatment is more than twice that before treatment.